Investment Summary

GIMV Invests In ImmunOs Therapeutics

On June 7, 2022, private equity firm GIMV invested in life science company ImmunOs Therapeutics

Investment Highlights
  • This is GIMV’s 24th transaction in the Life Science sector.
  • This is GIMV’s 5th transaction in Switzerland.

Investment Summary

Date 2022-06-07
Target ImmunOs Therapeutics
Sector Life Science
Investor(s) GIMV
Deal Type Venture

Target

ImmunOs Therapeutics

Schlieren, Switzerland
ImmunOs Therapeutics is a preclinical stage biotech company which develops a proprietary target discovery platform allowing to discover novel molecules inspired by HLA molecules and physiological immunosuppressive molecules. ImmunOs Therapeutics was founded in 2014 and is based in Schlieren, Switzerland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 153 of 170
Sector: Life Science M&A 24 of 24
Type: Venture M&A Deals 39 of 39
Country: Switzerland M&A 5 of 5
Year: 2022 M&A 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-24 Variotech

Nordhorn, Germany

Variotech is a manufacturer of innovative workpiece carriers, which are primarily used in fully automated manufacturing processes for transporting and handling components of various forms and sizes. The company’s customized products predominantly comprise reusable, exceptionally durable workpiece carriers that are manufactured almost exclusively from recycled materials by thermoforming. Variotech was founded in 1998 and is based in Nordhorn, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-09 Picot

Congrier, France

Picot produces fencing and gates, distributes its products through various channels to the private and corporate markets, and is also active in the installation of fencing solutions. Picot was founded in 1921 and is based in Congrier, France.

Buy -